How to Get Started on a GLP-1 Medication in 2026

GLP-1 medications for weight management are FDA-approved for adults who meet one of these criteria:

BMI of 30 or higher (classified as obesity) — no additional conditions required.

BMI of 27 or higher (classified as overweight) with at least one weight-related condition, such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea.

If you have type 2 diabetes, you may also qualify for GLP-1 medications (Ozempic, Mounjaro) specifically for blood sugar management, which are often covered by insurance more readily.

For the first time, you have a real choice between pills and injections:

Oral (daily pill): Oral Wegovy is now available. No needles, no refrigeration, easy to travel with. You'll take it each morning on an empty stomach with a small amount of water and wait 30 minutes before eating. Weight loss is approximately 80% as effective as the injection at comparable timepoints.

Injectable (weekly shot): Wegovy (semaglutide) and Zepbound (tirzepatide) are self-administered once per week using a pre-filled pen. The injection is subcutaneous (just under the skin) — similar to an insulin pen. Most patients say it's easier than expected. Injectables currently offer the highest efficacy, especially tirzepatide.

You have three main paths to get a GLP-1 prescription:

Your primary care doctor: If you have an established PCP, this is often the simplest route. They can prescribe, handle insurance prior authorizations, and monitor your progress. The downside: office visit scheduling and potential delays.

Telehealth providers: These platforms combine the medical consultation, prescription, and medication fulfillment into a single streamlined experience. You complete a health questionnaire, have a video or async consultation with a licensed provider, and get your medication shipped directly. Most can have you started within days.

Cash-pay manufacturer programs: NovoCare (for oral/injectable Wegovy) and LillyDirect (for Zepbound) allow you to purchase directly from the manufacturer at set prices, with a prescription from any licensed provider.

Every GLP-1 medication starts at a low dose and gradually increases over several weeks. This "titration" process minimizes side effects (primarily nausea) and lets your body adjust.

Semaglutide injectable: Start at 0.25mg weekly → increase monthly through 0.5mg → 1.0mg → 1.7mg → maintenance at 2.4mg. Full titration takes approximately 16-20 weeks.

Tirzepatide injectable: Start at 2.5mg weekly → increase monthly through 5mg → 7.5mg → 10mg → 12.5mg → maintenance at 15mg. Full titration takes approximately 20-24 weeks.

Oral semaglutide: Starts at lower doses with gradual increases. Your prescriber will guide the schedule.

Important: don't be discouraged if you don't see major weight loss in the first 4-8 weeks. The starting doses are intentionally low. The real results come at maintenance doses.

Days 1-3: Most patients report no noticeable effects at the starting dose. Some feel a mild decrease in appetite. This is normal — the dose is intentionally low.

Days 3-7: You may start to notice subtle appetite changes. Portions may seem larger, and you might feel satisfied sooner during meals. Some patients experience mild nausea, which typically improves within a few days.

Practical tips for week 1: Stay well hydrated (water is your best friend), eat smaller meals more frequently rather than large ones, avoid greasy or very rich foods (these tend to trigger nausea), and keep bland snacks on hand (crackers, toast) if needed.

Most side effects are mild and temporary. They tend to peak during dose increases and settle down within 1-2 weeks at each new dose level.